Bjorn Knollmann Archives
VUMC’s Knollman, Ware among new AAAS Fellows
Feb. 2, 2022—Vanderbilt's Ware, Knollman among new American Association for the Advancement of Science Fellows.
VUMC joins research network to fight atrial fibrillation
Jun. 14, 2018—Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.
Six Vanderbilt physicians honored by medical societies
May. 3, 2018—Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:
Nine new endowed chair recipients honored
Mar. 5, 2018—Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.
Knollmann to direct new arrhythmia research center
Jan. 14, 2016—Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).
New method aids heart disease studies, drug discovery efforts
Jan. 14, 2016—A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.
Normalizing calcium flux to treat atrial fibrillation
May. 12, 2014—A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
Reducing fatal rhythms after heart attack
Jul. 26, 2013—Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
Green tea for failing hearts?
Nov. 16, 2012—The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.
